Home arrow Home arrow Newsflash 3  
Main Menu
About Us
Medical Library
Global Network
World News
Contact Us
Terms of Use
Login Form

Lost Password?
No account yet? Register
Does another family member have Keratoconus ?
At what age were you diagnosed with Keratoconus ?

The Avedro Vedera KXS: Gold Winner of the Medical Device Excellence Award 2011  

 Vedera KXS
The Award Winning Avedro Vedera KXS Vision Correction Device
Avedro’s Vedera System® Wins Gold in the Medical Design Excellence Award.
Microwave Thermokeratoplasty with Corneal Collagen Cross-linking used to Treat Keratoconus
Studies of the combined procedure are currently under way in Europe and Turkey


The Lifetime Economic Burden of KC: A Decision Analysis Using a Markov Model
Rebenitsch RL, Kymes SM, Walline JJ, Gordon MO
Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri.

Purpose: To estimate the expected incremental lifetime cost of treatment of keratoconus compared to the expected cost of the treatment of myopia.
Design: Cost estimate from the patient's perspective using a Markov decision model.
Methods: We modeled a hypothetical cohort of people with clinically significant incident keratoconus as defined by the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. We included costs of clinic visits, fitting fees, contact lenses, surgical procedures, and complications. Survival curves of corneal transplants and associated complications were modeled using data from the 2007 Australian Graft Registry. Medical treatment regimens after surgery were defined by expert opinion.
Results: The expected value of the lifetime cost of the treatment of keratoconus over myopia was $25 168 with a standard deviation of $16 247 and a median of $17 596. The factors that most influenced the lifetime cost were the probability of initial corneal transplant and a subsequent regraft. The cost of routine care had relatively little influence on the lifetime cost of care.
Conclusions: The expected lifetime cost of treatment of keratoconus represents a significant cost to patients and payors. While the cost of routine care for keratoconus is not trivial, the primary factor influencing changes in the cost of care for keratoconus is the probability of corneal transplant. Combined with the significantly impaired vision-related quality of life and the relatively young onset of disease, the economic burden of the treatment of keratoconus represents a significant public health concern.
Am J Ophthalmol.

Something to shout about: The 6th International Congress of Corneal Cross-linking.

Milan, Italy, January 21 & 22, 2011.
The International Corneal Crosslinking Congress specializes in developing intuition in original thoughts and solutions to really maximize every patients visual potential, where ever they may be asking for more in the world.
The International Corneal Crosslinking Congress is where new breakthrough developments are independent from market forces, which in the end is what really gives patients maximum flexibility. What makes the International Corneal Crosslinking Congress unique is the experienced globe trotting in-house development teams, translating complex Keratoconus parameter requirements into deliverable benefits – where time to vision is crucial.
The International Corneal Crosslinking Congress are an experienced team of academics, medical and science driven professionals with industry leading innovators, specializing in visual need projection, implementing patient/clinical/medical and industry-scale future proofing care - a robust and accurate road map that is equipping us for the future, for happiness now. The people who make the International Corneal Crosslinking Congress what it has become today, come from culturally rich, diverse backgrounds, equals proficient in their fields who are highly determined to come together for the one wide-ranging quality they all have in common - the ability to deliver.
Listening and truly understanding each patient's visual requirements, medically and technically, allows us to provide innovative solutions. In order to attain this goal, at the International Corneal Crosslinking Congress, all the relevant aspects of modern corneal sciences was open for insightful analysis to enable and accelerate technological advancement. We are - Justifying Technologies - which translates into tangible benefits for patients; increased quality of care, an enhancement in freedom not feardom, cost reduction, getting your life back and speed to vision.
Below are the words to the 'three pillars' of the Global Keratoconus Foundation.

Always relishing a challenge, we are constantly exploring innovative ideas.


Always wanting to remove the two letters “i” and “m” from the word impossible – so making the impossible, a possible. Our real work is all about solving problems.


Always putting ourselves in the patients' position and then thinking about what we can do for them.
kcglobalA Good Sign 

Topo-aberrometric, Refractive and Pachymetric analysis of Keratoconics eyes undergoing CXL
Paolo Vinciguerra M.D.
E. Albé M.D.
S. Trazza Orthottist.

Click Here

Read More

Istituto Clinico Humanitas, University of Milan, Italy.

Live National Webcast on the 21st of October at 12:30 pm EST

 From this autumn there will be a series of National Webcasts
featuring first's on subjects such as
"Not a Lasik candidate", to a broadcast special on "Keratoconus"
Which can be seen at the Channel 4 website live
by logging on to news4jax.com
at 12:30 pm EST on the 21st of October

 Arun C. Gulani, M.D., M.S. will be answering questions submitted during this Webcast and others to follow, so you may send questions in advance by e-mailing:

This email address is being protected from spam bots, you need Javascript enabled to view it

When the Result Is Greater Than the Sum of the Parts

David Jory MBBS FRCOphth, Consultant Ophthalmologist
Advanced Surgery Center, The Technology Park, London.
CXL in the Treatment of Acute Post-Lasik Ectasia
Fellow of the Royal College of Ophthalmologists, Fellow of the Royal Society of Medicine, and Fellow of the Medical Society of London. 
Teaching faculty member of the American Society of Cataract & Refractive Surgery, and the European Society of Cataract & Refractive Surgeons.

Effects of Corneal Collagen Crosslinking on Corneal Topography, Visual Acuity and Contrast Sensitivity
Camila Netto MD ; Bruno Procópio MD ;
Ricardo Gomes dos Reis MD ; Mariana Pecego MD ; Lorena Vianna ;
Haroldo Vieira de Moraes Jr. MD, PhD ; Adalmir Morterá Dantas MD, PhD.

Click Here

Read More

Federal University of Rio de Janeiro, Brazil.

The World Ophthalmology Congress (WOC) Berlin 2010
The 32nd International Congress of Ophthalmology, the World Ophthalmology Congress (WOC) is the largest international congress of ophthalmology.
 WOC® 2010 awards medals to outstanding ophthalmologists

In the spirit of achievement and excellence at WOC 2010, Bruce Spivey, president of the International Council of Ophthalmology (ICO) awarded five ophthalmologists with medals for their outstanding work.

The prestigious Gonin Medal went to Dr Alan Charles Bird.

The International Duke Elder Medal was awarded to Dr Mohammad Daud Khan.

The Jules Francois Golden Medal went to Dr Gisele Soubrane, the first woman to ever receive a medal from the international council.

The ICO Ophthalmic Pathology Award went to Dr Ursula Schlotzer-Schrehardt.

Finally, Prof Peter G Watson, the current Academia Ophthalmologica Internationalis (AOI) president gave the Bernardo Streiff Gold Medal to Dr Gullapalli N Rao.

The Russian Hungarian Connection: Doctor Artsybashev Vs Keratoconus

Covered by our International News Correspondent

 Peter Goren

Click Here

Read More

Peter Goren is an American medical student at Semmelweis University in Budapest, Hungary.

For Your Viewing Pleasure: Optometric Management - Are Specialty Lenses for You?


Converse long enough with optometrists who operate thriving specialty contact lens practices,
and you will likely notice a recurring story. It involves a patient with a challenging
underlying condition (frequently Keratoconus) who goes from clinician-to-clinician,
sometimes for years...


Published by Optometric Management.

Light Travels: SimLC Nominated for the 2011 Innovation Healthcare Awards held in Dublin
 Health Award
Pictured above: Roisin Shorthall, the Minister of State for Primary Care, Department of Health in Ireland with Dr Arthur Cummings, Consultant Eye Surgeon, Wellington Eye Clinic and UPMC Beacon Hospital, Dublin.
Dr Arthur Cummings, MB ChB, FCS(SA), MMed (Ophth), FRCS(Edin), Wellington Eye Clinic, was recently nominated as a finalist for the 2011 Innovation Healthcare Awards, which were held at the Burlington Hotel in Dublin.
The nomination is for his invention “SimLC” for the treatment of Keratoconus. SimLC is a new methodology which brings together Corneal Cross Linking, and excimer laser technology in a harmonious way to bring about an unique resulting synergy to tackle Keratoconus.
Indications are that SimLC not only stops the progression of Keratoconus in 100% of cases, but in 70% of cases it actually improves uncorrected vision to increase the patients quality of life.

Keratoconus Management 


Computerized Corneal Tomography and Associated Features in a large New Zealand Keratoconic Population
Charlotte A. Jordan, Azra Zamri, Catherine Wheeldon, Dipika V. Patel, Richard Johnson, Charles N.J. McGhee

Purpose: To evaluate corneal tomographic features of Keratoconus and associations between risk factors and disease phenotype in New Zealand.

Setting: Departments of Ophthalmology, University of Auckland and Auckland District Health Board, Auckland, New Zealand.

Design: Clinic-based, cross-sectional study.

Methods: The medical records and corneal tomography of patients attending a subspecialty service were reviewed. Data included age, sex, ethnicity, ocular history, family history, atopy, and eye rubbing. Orbscan II parameters included simulated keratometry, mean power, pachymetry, location of maximum power, anterior best-fit sphere (BFS) and posterior BFS. Morphology was categorized by the Rabinowitz topography classification.

Results: Final analyses included 532 eyes (266 patients; 144 men) with a mean age of 29.3 years ± 11.56 (SD). Maori and Pacific patients were overrepresented (P=.0001). Family history of keratoconus was associated with a lower mean corneal power (P=.01) and greater pachymetry (P=.03). Comparing patients with family history and patients with atopy, showed differences in thinnest-point pachymetry (mean: family history, 340 ± 15 μm; atopy 381 ± 8 μm) (P=.0218). Keratoconus was classified as severe (58.3%) or moderate (33.8%) on mean keratometry. Axial keratometric maps were predominantly asymmetric bow-tie (29%), round (18%), or inferior steepening (17%). Anterior elevation maps were classified as spur (49.3%), island (24%), irregular ridge (15%), or other (11.3%). Eighteen patients (12.5%) had complete enantiomorphism.

Conclusions: Advanced Keratoconus was largely asymmetric and differences in tomographic phenotype were associated with differing etiologic risk factors. Maori and Pacific ethnicities were overrepresented in this population.

J Cataract Refract Surg.

Paulig Augenklinik is The World's First Ever Clinic for Keraflex Vision Correction

Medical TeamClinical Team
Paulig Augenklinik | Praxis. Bahnhofstraße 60, 03046 Cottbus, Germany.
Keraflex is being evaluated for Keratoconus patients in combination with collagen crosslinking as a synchronised procedure.


Doing Everything Humanly Possible: Keratoconus Patients in the News



 A Revolution in Corneal Reshaping and a Breakthrough in Accelerated Cross-linking. Live Surgery at ESCRS.


 ESCRS February 19, 2011 14:00, Hall 1 Convention Centre Live telecast from Cerrahpasa Medical Faculty, Eye Clinic, Prof. Faruk Yilmaz. 
Hands on demonstrations of the KXL™ System for Lasik Xtra - strengthen Corneas in minutes - in Avedro's Booth 113

Biomechanical Condition of the Cornea as a New Indicator for Pathological and Structural Changes
Prof. Dr. Eberhard Spörl
Prof. Dr. Lutz E. Pillunat

Click Here

Read More

University Hospital, Department of Ophthalmology, Dresden, Germany.

A World about Us: The APAO & AAO Joint Congress Beijing 2010

By Our International News Correspondent

 Jenny Deva MD

Held at the China National Convention Center (CNCC). The Joint Congress of the Asia-Pacific Academy of Ophthalmology (APAO) and the American Academy of Ophthalmology (AAO) in combination with the 15th congress of the Chinese Ophthalmological Society. The 2010 Joint Congress also celebrated the 50th anniversary (Golden Jubilee) of APAO.

CXL Skills Transfer Course forthe Asia & Pacific Region19/09/10
 Prof Theo Seiler, Dr Jenny P Deva, Dr Veera Ramani were the Instructors.
Participants were from China, Indonesia, India, Hong Kong and Singapore.


There was a whole symposium devoted to CrossLinking (CXL) for Keratoconus and Kera-ectasia. Professor Theo Seiler and  Prof Charles Mac Gheep resided over these meetings. 

Gala Dinner

Gala Dinner: Prof  Bruce Spivey (International Council of Ophthalmology) with delegates from China and Malaysia.

It was once again a meeting of great minds in every subspecialty of Ophthalmology. Beijing was beautiful. The slightly cooler than average weather temperatures made it a pleasant stay. It was certainly a meeting where landmark decisions was made for the future of Ophthalmological education.


Member of Parliament in New Zealand is Our Man in Politics

I am Aaron Gilmore a Member of Parliament for the Governing National Party in New Zealand and I have 'suffered' from Keratoconus for about 15 years now. Given my job I am walking proof that this annoying eyesight condition does not have to rule your life as though it is a pain, it does not need to make you a victim.

Aaron (pictured on the left) with the Campaign Bus

Campaign Bus

"He ain't heavy, his our brother" - flying!


Aaron's Website www.aarongilmore.org.nz
Party Website www.national.org.nz

Anterior Chamber Characteristics of Keratoconus Assessed by Rotating Scheimpflug Imaging

Illés Kovács MD, PhD, Kata Miháltz MDa, János Németh MD, DSca and Zoltán Z. Nagy MD, DSca

Click Here

Guest Access

Semmelweis University, Department of Ophthalmology, Budapest, Hungary.

More Than 30 years Distinguished Service for the Eye Care Industry


Irving Arons Irving Arons

Irving Arons

Irving Arons is a leading and highly experienced commentator on ophthalmic technology and industry issues.

Retired after more than 30 years of consulting in the ophthalmic and medical laser industries. Eleven years as managing director of Spectrum Consulting, including publishing Executive Laser Briefing; twenty-five years at Arthur D. Little, as manager of the Ophthalmic and Medical Laser Consulting Group.

Currently publishes :

  • The Irv Arons' Journal -- a record of many of his more than 150 published articles and columns; and,
  • The ADL: Chronicles -- briefs about some of the products and inventions that came out of the ADL Labs; and is,
  • Columnist for Ophthalmology World Report.
  • Contributing author to Eye Doc News.
  • Contributing author to the Society for Clinical Ophthalmology.
Only retired people know...

Only retired people know that retired people never really retire. People in the Industry who retire automatically become, by popular demand - teachers in the field, role models, mentors, commentators, opinion leaders. Retirement becomes one of discovery - new found time, new found freedoms, new social networking, and new current affairs to review, with a renewed independence.
Retirement allows the sharing of the three gifts - of life, love and laughter, given to you at birth
even more now with the rest of the world - and these gifts being special because they never diminish in size the more they are shared.

Remember, back in the day the industry's past and present seniors. They have been determined to extend themselves in pro bono efforts benefiting their fellow colleagues in the field, and they have made our community a better place to live.

It is never too late to seek a newer world.


Avedro Receives the European Union's CE Mark for its Vedera™ Ophthalmic Device

The company prepares for immediate commercial launch throughout Europe and Asia

Waltham, MA, April 20, 2010 — Avedro, Inc. today announced its Vedera™ System for performing the Keraflex® procedure has received the European Union's CE Mark. The CE Mark certifies the Vedera has met the EU's health and safety standards and opens the door to commercialization across the European Economic Community and in other countries recognizing the CE Mark.

"I am pleased by how quickly Avedro has been able to transform its Thermo-biomechanics platform technology into a commercially available ophthalmic device. Avedro has been conducting clinical trials to treat myopia and keratoconus with the Keraflex procedure and is extremely pleased with the results. CE Mark certification is an important milestone for the company, and also represents a vital new offering to ophthalmic patients and their physicians," said David Muller, PhD, President and CEO of Avedro.

The Keraflex procedure is a non-invasive, incision-less ophthalmic procedure for flattening the cornea. Because Keraflex thermally remodels the cornea without the removal of any tissue, the procedure offers the unique ability to induce refractive change without weakening the cornea's biomechanical integrity, as happens with LASIK and other refractive correction procedures.

Keraflex KXL, Corneal Flattening and Corneal Stabilization

In its European clinical trials for the correction of myopia and the treatment of keratoconus, a progressive disease of the cornea, Avedro has investigated a two-step procedure whereby Keraflex provides corneal flattening to achieve refractive correction and concomitant collagen crosslinking stabilizes the cornea.

"The Keraflex procedure, by thermally altering the tension of collagen fibers, induces a corneal flattening and achieves a more prolate cornea. This confers refractive correction, and, for the keratoconic cornea, smoothing of the irregular cornea, thereby improving visual acuity. The synergistic use of corneal collagen crosslinking improves the stability of the induced refractive effect while also working to halt disease progression," explains Prof. John Marshall, PhD, Institute of Ophthalmology, University College, London.

The company plans to immediately begin commercialization of the Keraflex procedure throughout Europe and Asia, and looks forward to training and collaborating with its ophthalmic surgeon partners.

About Avedro, Inc.

Avedro, a privately held medical device company based in Waltham, MA, is developing the science of Thermo-biomechanics for therapeutic medical applications. Keraflex® KXL is the first technology Avedro has developed from its Thermo-biomechanics platform. Avedro recently announced it has signed a definitive agreement with Peschke Meditrade GmbH to acquire the rights to its US-based Phase III studies of corneal collagen crosslinking for the treatment of progressive keratoconus and post LASIK ectasia. The company looks forward to closing the follow-up phase of the studies and completing the necessary steps to introduce crosslinking to the US market. For more information, visit www.avedro.com


Pregnancy Triggered Iatrogenic (Post-Laser in situ keratomileusis) Corneal Ectasia - A Case Report
Prema Padmanabhan, MS, Aiswaryah Radhakrishnan, MPhil, and Radhika Natarajan, FRCS.

Purpose: To report a patient who developed bilateral corneal ectasia, during pregnancy, one and a half years after laser in situ keratomileusis for correction of myopia.

Method: Case report with relevant literature review.

Results: A 20-year-old woman, with a stable myopic astigmatism underwent laser in situ keratomileusis for the correction of her refractive error. Preoperative clinical examination and topographic automated keratoconus screening did not suggest keratoconus in either eye. The patient had a preoperative corneal thickness of 527 and 525mm, and a postoperative residual bed thickness of 305 and 282mm in the right and left eyes, respectively. After being fully satisfied with the outcome of the procedure, she reported 18 months later, in the first trimester of pregnancy, with signs and symptoms of corneal ectasia, which steadily worsened with advancing pregnancy.

Conclusion: Pregnancy could prompt hormonal changes, which in turn could affect the biomechanical stability of the cornea, leading to corneal ectasia.

(Cornea 2010;00:000–000) 

News from the First Global Parent's Story: Fight Keratoconus in the First Round

 Dinas Son Good Times
 In the Army Dinas Son
Top Left: Dina's Son
Top Right: Family fun
Bottom Left: Following the family tradition in the Army
(2nd to the last of the soldiers)
Bottom Right: Dina's Son

I can't even begin to tell you how much this International Organization helped us when we first found out that my son has KC.

Almost 5 years ago my son was diagnosed with Kerataconus. The doctors here (Israel) pretty much just said: see you in a year. I found out about cross-linking, we flew him out to LA, where he (at the age of 14) had it done at Dr. Boxer-Wachler's office and every 6 months he gets his check ups. So far, his eyes have remained absolutely the same. Which is a minor miracle since his eyes had begun to deteriorate rapidly when he was first diagnosed.

We went the route of trying different kinds of contacts, but he felt pain in his eyes when he used them and he gave up on them. He has glasses now which corrects one eye. The other eye has just a clear lens since it can not be corrected.

In one month he will be 19, and this year he is doing a year's service for the country before enlisting in the IDF (Israel Defence Force). The year's service includes working with the youth movement in small villages, plus working with autistic children. He has grown up a lot these last few months, learning how to budget money with a small group of volunteers who all live together in a common house. They buy their food, use the money for travelling and whatever else they need. It's a good lesson for life in general.

As for the army, he got a low profile because of his Kerataconus which means he can't be in a combat unit. So who says Kerataconus is all negative? (don't tell him I said that). He has been accepted into an officer's training unit after his year's service is over, and hopefully he'll acquire skills there that he can use after his service. Both his sister and brother are officers in the army too. So is his Dad. That's what happens when a country is so tiny. Everyone helps out.

And I've learned all sorts of healing methods from Reiki, Rising Star, Matrix Energetics, Reconnective Healing. I have used them all on my son (in vain!). I'm still waiting for him to say: hey! I can see in both eyes!

I did help him when he had the flu. So I guess I can't complain...

 The Human Factor: Another Members Keratoconus Escapology
Keratoconus Member
Jamie and Kristin from Arizona, United States 
 Time - line
Date: 15 Dec 09
10,000 days since recorded Vision Loss

"My optometrist at the time (at the age of 12) never really caught my Keratoconus because he didn't have sophisticated equipment to screen for it.  The minute I went somewhere high tech...They
found it." - Kristin

4595 days since Diagnosis
"Keratoconus was diagnosed when I was age 20" - Kristin
4553 days since my specialist advised me to put my name down on the list for a corneal transplant

“This was advised to me as the only option I have, but from my
research in to this I have not needed to go that route" - Kristin

4320 days since getting maximum vision with maxium comfort I have ever had with contact lenses
“This was by finding a new optometrist purely by
chance from a recommendation, and from which a little known contact lens fitting
methodology was tried that works to this day” - Kristin

2541 days since an unheard of
change for the better in my Keratoconus

“This coincided with the fitting methodology used and/or when I changed to eating a more healthier diet and I started to take up more exercise. Over time, new contact lenses was being prescribed flatter and flatter, due my corneal topography each time getting flatter also, until the flattest possible contact lens available to my optometrist was prescibed for me, which is still the same prescription that is worn by me till this day” - Kristin

Implantable Lens Gives US Bobsled Captain Vision to Win Gold
 Steve Holcomb Credits the Visian ICL with Restoring His Eyesight and
Enabling Historic Victory.

Olympics Goldern Team
The Gold Winning Team
Jacksonville, Fl. -- March 6th, 2010 -- Just two years ago, U.S. Olympic bobsled team captain and gold medal winner was dealing with eyesight that was so impaired due to Keratoconus it threatened to end his bobsledding career.
Steve Holcomb
Team Captain Steve
"It got to a point in 2008 where I couldn't see anymore," Holcomb said in an interview with NBC.
"They couldn't make contacts strong enough. I went to my coach and told him I had to quit." But that was before Holcomb learned about the Visian ICL (Implantable Collamer Lens) - an implantable lens approved by the US FDA to treat patients with up to -20 diopters of nearsightedness. Holcomb had the Visian ICL implanted in both eyes, and his vision immediately improved from a reported 20/500 (legally blind) to 20/20.

With normal vision restored, Holcomb was able to resume his career and achieve Saturday's historic victory piloting the U.S. Bobsled four-man team to its first Olympic gold medal in 62 years.
The Visian ICL is made of Collamer, a proprietary, highly bio-compatible material that allows the lens to be rolled into a tiny cylinder for insertion into the eye during an outpatient procedure. Once inserted, the lens gently unfolds behind the iris, where it is tucked into place by the surgeon.

Implanted in more than 150,000 eyes worldwide, the Visian ICL offers a far wider treatment range for nearsightedness than LASIK.

Jacksonville Eye Surgeon, Keratoconus specialist and internationally renowned instructor, Dr. Arun Gulani has performed similar breakthrough cases. Surgery experience video of Jacksonville patient, Tony Shelton, who suffered with the identical eye condition as Steve Holcomb, is available below.
Tony Shelton
Tony Shelton & Dr Gulani
“This is a Miracle. I am amazed" - Tony
Dr. Gulani believes that Visian ICL is a great addition to out current modalities of correcting Keratoconus. Since ICL is used for High myopia, it can be utilized in cases of Keratoconus where the Myopia (nearsightedness) is extreme thereupon correcting it without impacting the thin cornea. The ICl can further be combined with CXL/ C3R, INTACS, Lamellar corneal surgery and Laser surgery.

News from the First Global Patient's Story of Corneal Crosslinking

Keratoconus Member and Founder of the Bulgarian Keratoconus Association
It's been almost five years since I returned home to Bulgaria from Dresden, Germany, where kind and professional people at the Carl Gustav Carus Faculty of Medicine did the new, at the time, procedure called Crosslinking and where I had my Crosslinking treatment. As Crosslinking is the first ever treatment for Keratoconus and invented at the Technische Universität Dresden, it was Dresden, the natural choice, where long ago I had my Crosslinking treatment.

These where memorable days for me as they changed my life. It was the time that I learned not only from friends from our forum, but also from my personal experience, the subtleties of the condition. It took me two years to realize from research that hard lenses are more dangerous than is usually discussed, and they should be "handled with care” by being used with extreme caution and attention. This was the time in which my eye sight worsened and the cornea's of my eyes distorted, because of the constant rubbing that I experienced with badly fitted hard lenses (which I did not know at the time was happening). I had just found a good optician that fitted me perfectly in hard lenses in Greece, when I contacted German professionals, and after which Corneal Crosslinking was performed to treat my Keratoconus one time.

After the first months passed my vision stabilized. I am glad that after five years I can say that my vision has stayed the same. I was fitted with glasses once my vision had stabilized, and since then I am still wearing glasses when before only hard lenses could correct my vision. Recently the parameters for my glasses were slightly changed; this was because my current optician did a better refraction examination for the fitting of my glasses, not because the eye had changed. To say the least, I am eternally grateful for the vision and the life I have now. I am still using glasses reaching 100% correction from both eyes.

I still sometimes remember that my eyes are not perfect, but also that they are perfect considering the fact I can wear glasses now fully, and this was only due to having Crosslinking alone as a treatment, which was a great bonus in my case. To me able to wear glasses comfortably without the need (or the need to endure the on-going risks) of medical contact lenses is nothing short of an absolute blessing to be able to do, and everyones right to be able to do with out the need for not only invasive contact lenses but also invasive surgery, and the chance for this should be made available for them. I find my eyes are more relaxed while reading than before treatment, with there being now better uncorrected vision also. You know, I stay 9 to10 hours per day in front of the PC at work. I am still trying to change this habit, but work is something which is mandatory for me..

In the early days before I knew not to, I used to rub my eyes using fingers in to my eyes when using the palm of my hands would have been better, now I know its better to avoid any trauma to the eye altogether. During the time I had to use hard lenses - whilst putting them in to my eyes and taking them out, there was plenty of friction and rubbing caused as well. I used to put pressure on my eyes without realizing the damage I was doing. After I changing my attitude, and after my Crosslinking treatment, I managed to stabilize my vision and from that have been able to live a normal life up to now. It is a great feeling to finally being treated and having eyes which are strong now at the front, when previously they where not. What was needed from my side to achieve this was so little and simple. I just started handling my eyes with more care, and by doing so, getting the eye care that was required as equally, and as early and as quickly as I could, which is what reaped its rewards. What I was sure about was since my first report on my treatment, Crosslinking would (and has) become available to patients globally.

There is no way to predict the distant future to come, but reading the news of the latest advances in medicine, I feel very positive that most and hopefully all of us will cope in a certain way with this condition, and we will have the chance to live our lives, full of value.

Keraflex and Annular Collagen Crosslinking: A New Treatment Modality for Keratoconus
Peter S. Hersh, M.D. Cornea and Laser Eye Institute – Hersh Vision Group

Click Here

Read More

CLEI Center for Keratoconus Professor,
UMDNJ Medical School Visiting Researcher, Princeton University.

The 5th International Congress of Corneal Cross Linking
Medical Vision Professionals from around the world converged for the 5th International (CXL) Congress of Corneal Cross Linking, on the 4th and 5th of December 2009 in Leipzig, Germany.

The congress again created a thriving environment for the disseminate of information about the actual treatment of primary and secondary corneal ectasia; and for their champions around the world to discuss, learn, demonstrate and act on the benefits and lessons learned from Visual Scientists and Medical Vision Professionals in leadership. Their quantum cutting edge medical breakthrough achievements have been of a monumental magnitude, a recountal of legendary standards to be told for generations to come.

Since the safety and efficacy profile of Corneal Crosslinking, the first ever treatment for Keratoconus (KC), has been demonstrated many times over and confirmed as being excellent Internationally from gaining comprehensive and long term results; the Intercontinental cooperation has aligned itself more with wider educational and scientific programs, conceptualized as early as in 2005 during the inauguration of the first International (CXL) Congress of Corneal Cross Linking in December 9-10, 2005 in Zurich, Switzerland. Since then the congress has brought together a multifold, multidisciplinary field-force of Medical Vision Professionals from all corners of the world, representing famous International Hospitals, world-class Institutes to world renowned Universities, all of whom came together to find the best the world can offer - and to which they definately found. This was up-to-date congressional knowledge with precise pinpoint medical accuracy.

Cooperation is made up nowadays of a huge influx of extensive projects and initiatives, launched and implemented by medical academic scholars in their respected specialisms. This natural fostering of high methodical standards in science, and the availability of better options for the emergence of new audiences, makes them unbeatable as Medical Vision Professionals Internationally. The CXL Congress has always been where the our brightest, and the highest caliber of medical delegates have converged to, in order for - Safety, Quality and Teamwork - as never seen before, and which has been always continually constant.

The CXL Congress make things happen which otherwise would not have happened. They are involved with global positive results, which in turn have won robust life long, unsurpassed working relationships internationally, devoted good will, fellowships with rapport, and in return they give back great everlasting memories in humanity, all which transcend absolutely everything as global citizens.
kcglobalA Good Sign

Advanced Laser Surgery for Keratoconus: Patient Questions Dr. Gulani

 Biomechanical and Histological changes after Corneal Crosslinking with and without Epithelial Debridement

Gregor Wollensak MD and Elena Iomdina MD

Click Here

Guest Access

From the Eye Laser Institute, Department of Ophthalmology (Wollensak), Martin-Luther-University, Halle, Germany, and Moscow Helmholtz Research Institute of Eye Diseases (Iomdina), Moscow, Russia. 


Global Keratoconus Foundation - 2017 © All rights reserved